SPH3643: A novel cyclin‐dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood‐brain barrier permeabilityXuemei Liao(Chinese University of Hong Kong), Yanjun LiuCancer ScienceFebruary 27, 202010.1111/cas.14367Cited by 18SaveCiteExport RISWatch citationsRelated PapersTryptanthrin Inhibits Angiogenesis by Targeting the VEGFR2-Mediated ERK1/2 Signalling Pathway|PLoS ONE|2013|58